| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2020
|
131.00 | 62.4B | 14.43 | 2.79 | 9.94 | 41.6% | 10.6% | 74 | 70 | 174.04 | +24.6% | 98 | 0.01 |
|
2210
|
18.74 | 440.8M | 5.66 | 1.57 | 5.18 | -20.9% | 7.3% | 65 | 30 | 43.12 | +83.2% | 36 | 2.15 |
|
2250
|
12.20 | 8.1B | — | 0.95 | — | -0.7% | 11.6% | 61 | 37 | 21.72 | +37.5% | 86 | 0.00 |
|
2170
|
27.16 | 1.9B | — | 0.56 | 16.28 | -1.4% | 11.2% | 59 | 36 | 51.93 | +51.1% | 75 | 0.08 |
|
2010
|
49.78 | 149.3B | — | 1.00 | 10.23 | -0.7% | 9.2% | 56 | 39 | 74.73 | +28.1% | 69 | 0.26 |
|
2060
|
9.00 | 6.0B | 19.62 | 0.60 | 5.61 | -1.8% | 8.8% | 56 | 31 | 16.66 | +50.2% | 52 | 0.56 |
|
2310
|
13.27 | 9.6B | 64.43 | 0.65 | 8.27 | 1.2% | 10.3% | 53 | 25 | 16.25 | +16.2% | 68 | 0.15 |
|
2330
|
23.75 | 6.2B | 27.20 | 1.78 | 18.76 | 5.2% | 8.6% | 44 | 49 | 22.20 | -4.4% | 33 | 2.72 |
|
2350
|
5.29 | 7.9B | — | 0.86 | 24.77 | 3.0% | 8.6% | 43 | 38 | 5.45 | +1.7% | 30 | 1.00 |
|
2290
|
34.04 | 19.1B | 100.00 | 1.78 | 16.75 | -0.0% | 11.6% | 41 | 28 | 29.88 | -6.8% | 88 | 0.01 |
|
2300
|
65.90 | 2.4B | 56.43 | 4.18 | 20.79 | 10.4% | 11.4% | 30 | 34 | 32.18 | -36.8% | 59 | 0.99 |
|
2380
|
17.55 | 38.6B | — | 2.96 | 117.70 | 1.1% | 8.8% | 21 | 26 | 6.82 | -31.2% | 20 | 1.93 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.